Stef Baas

Stef Baas

Auto-generated profile, based on publicly available information

Stef Baas

MRC Biostatistics Unit, University of Cambridge, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2022 in Omega
Verified
Journal Article
Open access
SDSander Dijkstra
Sander Dijkstra
SBStef Baas
Stef Baas
ABAleida Braaksma
Aleida Braaksma
RBRichard J. Boucherie
Richard J. Boucherie
This paper introduces mathematical models that support dynamic fair balancing of COVID-19 patients over hospitals in a region and across regions. Patient flow is captured in an infinite server queueing network. The dynamic fair balancing model within a region is a load balancing model incorporating a forecast of the bed occupancy, while across regions, it is a stochastic program taking into account scenarios of the future bed surpluses or shortages. Our dynamic fair balancing models yield decision rules for patient allocation to hospitals within the region and reallocation across regions based on safety levels and forecast bed surplus or bed shortage for each hospital or region.

19 May 2025 in Computational Statistics & Data Analysis
Verified
Journal Article
Closed access
SBStef Baas
Stef Baas
PJPeter Jacko
Peter Jacko
SVSofia S. Villar
Sofia S. Villar

19 January 2026 in Statistical Methods in Medical Research
Verified
Journal Article
Open access
ETEdwin Yn Tang
Edwin Yn Tang
SBStef Baas
Stef Baas
DKDaniel Kaddaj
Daniel Kaddaj
LPLukas Pin
Lukas Pin
DRDavid S Robertson
David S Robertson
SVSofia S. Villar
Sofia S. Villar
Response-adaptive randomization (RAR) can increase participant benefit in clinical trials, but also complicates statistical analysis. The burn-in period—a non-adaptive initial stage—is commonly used to mitigate this disadvantage, yet guidance on its optimal duration is scarce. To address this critical gap, this paper introduces an exact evaluation approach to investigate how the burn-in length impacts statistical operating characteristics of two-arm binary Bayesian RAR (BRAR) designs. We show that (1) commonly used calibration and asymptotic tests show substantial type I error rate inflation for BRAR designs without a burn-in period, and increasing the total burn-in length to more than half the trial size reduces but does not fully mitigate type I error rate inflation, necessitating exact tests; (2) exact tests conditioning on total successes show the highest average and minimum power up to large burn-in lengths; (3) the burn-in length substantially influences power and participant benefit, which are often not maximized at the maximum or minimum possible burn-in length; (4) the test statistic influences the type I error rate and power; (5) estimation bias decreases quicker in the burn-in length for larger treatment effects and increases for larger trial sizes under the same burn-in length. Our approach is illustrated by re-designing the ARREST trial.

2 September 2025 in Annals of Operations Research
Verified
Journal Article
Open access
PDF file
SBStef Baas
Stef Baas
ABAleida Braaksma
Aleida Braaksma
RBRichard J. Boucherie
Richard J. Boucherie
A constrained Markov decision process (CMDP) approach is developed to construct response-adaptive procedures in clinical trials with binary outcomes. The resulting CMDP class of Bayesian response-adaptive procedures can target a certain objective, such as maximizing expected treatment outcomes, while using constraints to control other operating characteristics such as the type I error rate. The constraints can be formulated under different priors, enforcing control of trial operating statistics given that the parameters lie in a specific part of the parameter space (e.g., following from a statistical hypothesis). A solution method is developed to find an optimal policy, while we propose a computationally efficient method based on a cutting plane algorithm that uses backward recursion at every iteration, yielding a feasible policy accompanied by a respective optimality gap. In three applications, we impose constraints on the Bayesian average (i.e., a priori expected) type I error rate, power, and mean-squared error, and a constraint on prior robustness. Comparison of the constructed CMDP procedures with the constrained randomized dynamic programming procedure shows a stronger frequentist type I error control and similar performance in the other operating characteristics when constraining the Bayesian average type I error rate, power, and mean-squared error, whereas CMDP additionally shows substantial outperformance in terms of expected treatment outcomes when only constraining the type I error rate and power. The third application shows that the CMDP approach provides a previously unexplored way to construct response-adaptive procedures with a desired degree of robustness to prior misspecification in terms of expected treatment outcomes.

18 December 2024 in Omega
Verified
Journal Article
Open access
HBHayo Bos
Hayo Bos
SBStef Baas
Stef Baas
RBRichard J. Boucherie
Richard J. Boucherie
EHErwin W. Hans
Erwin W. Hans
GLGréanne Leeftink
Gréanne Leeftink

6 August 2024 in Journal of Multivariate Analysis
Verified
Journal Article
Open access
SBStef Baas
Stef Baas
JFJean-Paul Fox
Jean-Paul Fox
RBRichard J. Boucherie
Richard J. Boucherie
A Bayesian covariance structure model (BCSM) is proposed for interval-censored multi-way nested survival data. This flexible modeling framework generalizes mixed effects survival models by allowing positive and negative associations among clustered observations. Conjugate shifted-inverse gamma priors are proposed for the covariance parameters, implying inverse gamma priors for the eigenvalues of the covariance matrix, which ensures a positive definite covariance matrix under posterior analysis. A numerically efficient Gibbs sampling procedure is defined for balanced nested designs. This requires sampling latent variables from their marginal full conditional distributions, which are derived through a recursive formula. This makes the estimation procedure suitable for interval-censored data with large cluster sizes. For unbalanced nested designs, a novel (balancing) data augmentation procedure is introduced to improve the efficiency of the Gibbs sampler. The Gibbs sampling procedure is validated in two simulation studies. The linear transformation BCSM (LT-BCSM) was applied to two-way nested interval-censored event times to analyze differences in adverse events between three groups of patients, who were randomly allocated to treatment with different stents (BIO-RESORT). The parameters of the structured covariance matrix represented unobserved heterogeneity in treatment effects and were examined to detect differential treatment effects. A comparison was made with inference results under a random effects linear transformation model. It was concluded that the LT-BCSM led to inferences with higher posterior credibility, a more profound way of quantifying evidence for risk equivalence of the three treatments, and it was more robust to prior specifications.